The maize lethal necrosis (MLN) artificial inoculation screening site in Naivasha, Kenya will begin its second screening cycle of 2017 at the end of October, interested organizations from both the private and public sectors are invited to send maize germplasm for screening.
In 2013, the International Maize and Wheat Improvement Center (CIMMYT) and the Kenya Agricultural & Livestock Research Organization (KALRO) jointly established the MLN screening facility at the KALRO Naivasha research station in Kenya’s Rift Valley with support from the Bill & Melinda Gates Foundation and the Syngenta Foundation for Sustainable Agriculture.
Artificial inoculation of maize germplasm at the Naivasha MLN screening site, Kenya. Photo: B.Wawa/CIMMYT
The new maize lethal necrosis (MLN) online portal provides up-to-date information and surveillance tools to help researchers control and stop the spread of the deadly disease.
MLN was first reported in Kenya in 2011 and has since then been reported in several countries in eastern Africa, especially the Democratic Republic of the Congo, Ethiopia, Kenya, Rwanda, Tanzania and Uganda. The disease kills plants before they can grow, and the pathogens are transmitted by insects or contaminated seed. Serious damage to the region’s maize production from MLN has impacted household food security.
Artificial inoculation of maize germplasm at the MLN screening site in Naivasha, Kenya. Photo: B. Wawa/CIMMYT.
The first screening activity for the 2017A planting cycle from March to May is set to begin in May 2017 at the joint Kenya Agricultural and Livestock Research Organization (KALRO)–International Maize and Wheat Improvement Center (CIMMYT) maize lethal necrosis (MLN) artificial inoculation screening site at Naivasha, Kenya.
Deadline for interested private and public sector organizations to send their maize germplasm for screening is March 30, 2017 to enable processing imports and clear seed shipment that takes between six to eight weeks. Planting is due to start at the first week of May 2017.
Since its establishment in 2013 as a response to the MLN outbreak, the screening facility has so far screened over 60,000 entries from 16 private and public institutions including seed companies and national research organizations in Africa and beyond. The facility was established with support from the Bill & Melinda Gates Foundation and the Syngenta Foundation for Sustainable Agriculture.
In the fight to prevent and control the spread of maize lethal necrosis (MLN) across Eastern Africa, the support and cooperation of everyone involved in maize production is crucial—especially farmers. This was the main focus of CIMMYT’s 4th stakeholders meeting, held 15 October in Kenya, which brought together 56 local farmers as well as community leaders, administrators, government extension officers, KALRO and CIMMYT staff. The meeting was held to share new information on MLN and agree on the best methods to control the incidence and spread of the disease.